httppayai

agents.writerslogic.com

Mines ClinicalTrials.gov for terminated, withdrawn and suspended studies and for completed Phase 1/2 non-industry studies with no later industry Phase 2/3/4 trial, joins Europe PMC and OpenAlex literature, classifies why each was shelved (keyword rules; one fast model call only for an ambiguous reason or a missing mechanism, verified by verbatim quote), checks ChEMBL and the FDA Orange Book for approved, withdrawn or boxed-warning molecules, and strictly excludes any candidate with a safety, toxicity or drug-versus-placebo adverse-event excess. Returns a Repurposing Dossier per survivor: trials with NCT links, mechanism, shelving reason, safety/dosage data, IP window estimate, US regulatory pathway with non-compliant routes flagged, evidence grade, computed concerns and a deterministic de-risk score. One candidate failing does not discard the others. Not medical or regulatory advice.